Bradley Sitko
Chief Investment Officer chez XOMA CORPORATION
Fortune : 221 655 $ au 31/03/2024
Profil
Bradley J.
Sitko is currently a Managing Director at RTW Investments and a Chief Investment Officer at XOMA Corp.
He was previously a Director at MTS Health Partners LP from 2008 to 2015, a Vice President-Finance & Corporate Development at DNAnexus, Inc. from 2015 to 2019, and a Director at RTW Investments ICAV from 2021 to 2023.
He also held a position as a Chief Financial Officer at Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Additionally, he has worked as a Principal at Pfizer Inc. Mr. Sitko received his undergraduate degree from the University of Pennsylvania and his MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XOMA CORPORATION
0,06% | 18/03/2024 | 7 100 ( 0,06% ) | 170 755 $ | 31/03/2024 |
| 02/10/2023 | 2 000 ( 0,13% ) | 50 900 $ | 31/03/2024 |
Postes actifs de Bradley Sitko
| Sociétés | Poste | Début |
|---|---|---|
| XOMA CORPORATION | Chief Investment Officer | 03/01/2023 |
RTW Investments /Venture/
 RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Private Equity Investor | 01/11/2019 |
Anciens postes connus de Bradley Sitko
| Sociétés | Poste | Fin |
|---|---|---|
| RTW Investments ICAV | Director/Board Member | 01/01/2023 |
DNAnexus, Inc.
 DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Director of Finance/CFO | 01/01/2019 |
MTS Health Partners LP
 MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Director/Board Member | 01/03/2015 |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Director of Finance/CFO | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formation de Bradley Sitko
| University of Pennsylvania | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| XOMA CORPORATION | Health Technology |
| Entreprise privées | 5 |
|---|---|
DNAnexus, Inc.
DNAnexus, Inc. Packaged SoftwareTechnology Services DNAnexus, Inc. develops a cloud-based data analysis and management platform for DNA sequence data. It engages in the provision of cloud-based solutions for large-scale Deoxyribonucleic acid (DNA) data management and analysis. The firm offers a centralized hub for managing data, collaborating with other scientists, sharing tools, and accessing diverse reference datasets, including genotypic and phenotypic data. The company was founded by Serafim Batzoglou, Andreas Sundquist and Arend Sidow in 2009 and is headquartered in Mountain View, CA. | Technology Services |
MTS Health Partners LP
MTS Health Partners LP Investment Banks/BrokersFinance MTS Health Partners LP provides strategic and financial advisory services to healthcare companies from global corporations to venture backed businesses. Its strategic advisory alternatives include mergers, acquisitions, company sales, divestitures, recapitalizations, restructurings, general strategic advisory, financing oversight and oversight opinions. The firms financing solutions include traditional private convertible preferred issuances, cross-over focused convertible transactions, common stock and structured/convertible PIPEs, registered direct and acquisition financings, secondary sales, special situations, structured debt financings and royalty monetization. The company was founded by Curtis Scott Lane in 2000 and is headquartered in New York, NY. | Finance |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
| RTW Investments ICAV | Miscellaneous |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. Pharmaceuticals: MajorHealth Technology Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. is a Chinese company that develops and commercializes novel therapeutics. Yan Ping Mou has been the CEO of the company since 2023. | Health Technology |
